Conferences
A
- AACR Annual Meeting
- ACCC National Oncology Conference
- AMP Annual Meeting
- ASCO Annual Meeting
- ASCO Annual Meeting: GI Spotlight
- ASCO Gastrointestinal Cancers Symposium
- ASH Annual Meeting
- ASH MPN Spotlight
- ASH Multiple Myeloma Meeting Spotlight
- ASH23 Spotlight: Mezigdomide in RRMM
- ATA Annual Meeting
- AUA Annual Meeting
- Annual International Congress on Hematologic Malignancies
- Annual School of Breast Oncology
I
- IASLC World Conference on Lung Cancer
- ILCA Annual Conference
- ISGIO Annual Conference
- Inaugural Miami Cancer Institute Precision Oncology Symposium
- Interdisciplinary Prostate Cancer Congress and Other Genitourinary Malignancies
- International Congress on MPN
- International Kidney Cancer Symposium
- International Myeloma Society Annual Meeting
- iSPOR
N
S
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves T-DXd Plus Pertuzumab for HER2-Positive Breast Cancer
2
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
3
Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes
4
FDA Fast-Tracks Muzastotug Combo in MSS Metastatic Colorectal Cancer
5
